Prosecution and licensing of patents and utility models, including opposition and appeal proceedings before the European Patent Office and nullity proceedings before the German Federal Patent Court; patent infringement litigation, including opinions on the validity and the scope of patents, such as freedom-to-operate and due-diligence analysis.

Thomas Friede specializes in the following technical fields: gene technology, biochemistry, molecular biology, gene therapy, cell biology, immunology, virology, pharmaceutical and organic chemistry, DNA arrays, medical devices and chemical engineering.

In the recent past, Thomas Friede successfully defended a patent relating to a therapeutic substance before a Board of Appeal of the European Patent Office while another important case related to a diagnostic assay. In a current case, Thomas Friede is part of a BARDEHLE PAGENBERG team of patent attorneys and attorneys-at-law litigating a medical device patent of a US manufacturer.

Thomas Friede regularly publishes articles on his fields of practice in legal and business journals (see publications).

1993–1996	Research biochemist at the German Cancer Research Center, Heidelberg, in the fields of molecular immunology and autoimmune diseases
1997–2000	Trainee at two German patent law firms
2002–2004	Associate at patent law firm Grünecker, Kinkeldey, Stockmair & Schwanhäusser, Munich
2004-2009	Associate at Bardehle Pagenberg Dost Altenburg Geissler, Munich
Since 2010	Partner of the firm

1987–1993	Studied Biochemistry at the University of Tübingen, Germany
1993	Graduated with a degree in Biochemistry
1996	Awarded “Dr. rer. nat.” (PhD) degree, University of Tübingen
2001-2002	Trainee at the District Court Munich, German Patent and Trademark Office and Federal Patent Court
2002	Admitted as German Patent Attorney and European Patent Attorney

German, English, French